Subscribe to our RSS feeds RSS | Login | Register  
 

Headliner: Merz North America's Jack Britts

Tanya Lewis October 13, 2008

On September 2, Jack Britts was named president & CEO of Merz Pharmaceuticals, the North American subsidiary of privately held German firm Merz GmbH & Co.
 

Specialty Spiral

Eugene M. May October 13, 2008

It was a dismal six months for specialty journals with only optometry posting a marginal gain in ad spend; the other seven sectors registered losses. PERQ/HCI's Eugene M. May reports on the biggest advertisers for the first-half of 2008
 

The anatomy of an email

Terry Nugent October 13, 2008

Email is one of the most effective ways to drive traffic and get your preferred marketing message across. Terry Nugent looks at what attributes help make a campaign effective and offers advice on the right way to go about 'buying' email marketing
 

How to work together

Deborah Dick-Rath October 13, 2008

Over one-third of new pharma products are developed through strategic alliances. It is essential to learn to function productively within them. Deborah Dick-Rath offers some pointers
 

Sales Force Report: Loop of Faith

Anthony Vecchione October 13, 2008

The traditional sales force model is undergoing a metamorphosis. Anthony Vecchione reports on how pharma companies are investing heavily in closed-loop marketing as they look for new ways to gain insight into how physicians want to receive information
 

Headliner: AngioGenex's William A. Garland, PhD

Tanya Lewis September 12, 2008

After nearly 20 years at Hoffmann-La Roche, William A. Garland, PhD, left big pharma in 1994 to direct research and development for a number of early-stage biotechs, including Lpath and Tosk.
 

Medical/Surgical Journal Ad Review

Eugene M. May September 12, 2008

With the lowest first-half spend since 2003, the top journals are left wondering if their luck will ever turn around. Eugene M. May reports on the few bright spots in the medical/surgical sector
 

Data-Driven DTP

Julian Parreno September 12, 2008

Utilizing an effective marketing strategy can go a long way in maximizing the lifetime value of a pharmaceutical brand. Harte-Hanks' Julian Parreno looks at how Shire Pharmaceuticals overcame myriad competitive and regulatory obstacles to market its latest ADHD treatment, Adderall XR
 

Social Etiquette

Gil Bashe September 12, 2008

Just as it followed other sectors into CRM, the pharma industry must find entry points into the online patient conversation. Gil Bashe explores some of the issues, hurdles and opportunities of Web 2.0
 

The Age of Engagement

Ben Comer September 12, 2008

There's more to patient programs than simply telling folks what to do. Ben Comer looks at ways to drive actions